Leah Dewey, VP of Clinical and Consumer Engagement Operations, Cotiviti
According to the Centers for Disease Control and Prevention (CDC), rural Americans have a higher risk of premature death from heart disease, cancer, respiratory disease,…
Continue Reading
Source Credit: Boehringer Ingelheim & Eko Health
What You Should Know:
– Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced…
Continue Reading
Joseph Siemienczuk, MD, Medical Advisor for Clinical Solutions at Cedar Gate Technologies
Poorly managed and uncontrolled chronic diseases are the leading cause of death and disability in the United States, and represent a growing national…
Continue Reading
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection.
What You Should Know:
– AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its…
Continue Reading
AI-driven heart scans which cut the need for invasive tests have saved millions of pounds, according to an analysis.
The Heartflow technology, which has been rolled out across 56 hospitals in England since 2021,…
Despite significant advances, the prevention and management of cardiovascular disease remain challenging, especially for ischemic heart disease (IHD). Current clinical decision-making relies heavily on physician expertise, guideline-directed therapies, and static risk scores, which often…
Continue Reading
AI Calibration Enhances Heart Disease Detection
Groundbreaking research reveals that calibrating scores from an artificial intelligence algorithm significantly improves the identification of patients at high risk for hypertrophic cardiomyopathy (HCM). This potentially life-threatening heart condition…
Background: Utilizing digital health technologies to aid individuals in managing chronic diseases offers a promising solution to overcome health service barriers such as access and affordability. However, their effectiveness depends on adoption and sustained…
Continue Reading
What You Should Know:
– Leidos is committing $10M to a five-year collaboration with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) to accelerate the development and use of artificial intelligence…
Continue Reading
Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases.The company is working with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE)…
Continue Reading
